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satisfactory images at about that gestational age Introduction 
Ultrasound scan is the main tool in the prenatal using the transabodominal probes. With 
detection of congenital abnormalities. It allows improved technology, in particular the 
the examination of internal and external development of the transvaginal ultrasound 
anatomy of the fetus and the detection of not probes, it has become possible to examine the 
3fetal anatomy in details in the first trimester . The only major defects but also subtle markers for 
1chromosomal abnormalities . In addition the potential advantages of such early screening are 
ultrasound scan has found a vital use in the study numerous and include the early detection of 
of the blood flow patterns in both the non-viable fetus, major fetal abnormalities, 
3, 4, 5.
plural pregnancies and their chorionicity   uteroplacental and fetoplacental circulations, 
Ultrasound at this stage can be used either for which are referred to as the doppler. Modern 
primary diagnosis or secondary diagnosis (as a antenatal care worldwide offers ultrasound scan 
guide to invasive procedures). Studies have as part of screening service for both maternal 
shown that pregnant woman prefer first and fetal disorders. Traditionally however, the 
trimester rather than second trimester terminology “prenatal screening” refers to 
2screening for fetal abnormality . 
There are numerous reports on the value of 
ultrasound prenatal screening at 18-23 weeks 
commonly referred to as anomaly scan. This is 
the routine in most antenatal care units, partly 
because available scans can only produce 
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Abstract
Background: Congenital abnormalities are one of the important contributors to perinatal 
morbidity and mortality worldwide. The prenatal screening for these conditions is one of the 
major aims of a good antenatal unit. Over the years there has been a gradual change in the 
approach used, especially with the introduction of first trimester ultrasound as a reliable 
screening method.
Objective: To give a comprehensive review of the basis for first trimester ultrasound screening 
for congenital abnormalities, it's utilization in the prenatal screening for chromosomal, 
structural and genetic abnormalities as well as its limitations. 
Source: An electronic database search and review of relevant literatures with the use of the 
following keywords: first trimester screening, ultrasound scan, nuchal translucency and 
prenatal screening. Manual search was also conducted for recent issues of key journals and 
current texts.
Conclusion: The first trimester scan has been proven to be an equally effective method of 
prenatal screening for congenital abnormalities compared to older methods of screening. It is 
recommended for implementation in antenatal units especially in developing countries. There 
is however, the need for proper training and regular auditing of results to achieve the best 
result. 
Key words: First trimesters scan, Nuchal Translucency (NT), Prenatal screening, Congenital 
abnormalities.
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6screening . There has also been a rising interest a few women, early prenatal screening allows 
in the use of the ultrasound to screen for them to adjust to the birth of an affected child 
congenital malformation by researchers in that they would not abort.
recent times. Literatures on such researches are 
however scanty and are not usually available to First trimester screening implies ultra 
+6
many practitioners. sonography conducted between 11 and 13  
weeks of pregnancy. Eleventh week is 
The paper will review the available literatures on recommended as the earliest gestation for 
first trimester ultrasound screening, the conducting prenatal ultrasound screening for 
scientific basis and scope of diagnosis as its two reasons. Firstly the follow up diagnostic test, 
limitations. It shall also review its advantages and chorionic villus sampling (CVS) is not advised to 
disadvantages as well as application in special be done at an earlier gestation because of the 
circumstances. higher risk of oromandibulofacial deformities 
(OFMD), transverse limb deformities and 
9, 11abortion . Secondly, some fetal structures Basis for First Trimester Screening
could not be differentiated before this gestation. A lot of literature is available that report on 
For example, the four-chamber heart view is only common methods of screening for congenital 
demonstrable after 10 weeks, while the fetal malformations in pregnancy. Most of the 
bladder can be visualized in 80% of cases at 11 methods are done in the second trimester of 
weeks and 100% by 12 weeks.pregnancy.
+6Selecting an upper limited of 13  weeks also has Screenings for structural anomalies are usually 
well deserved reasons. First, it is thought that achieved with the scan performed at about the 
one of the options utilized in an affected 18-23 weeks of pregnancy or through the 
situation is pregnancy termination. Studies have determination of certain biochemical markers 
shown that most women would terminate an such as alpha-fetoprotein. In the best of centers, 
affected pregnancy following prenatal about 1% of report structural abnormalities are 
1 27 diagnosis . An early or first trimester detected by antenatal sonography . In most 
termination is less hazardous. Secondly, the developing countries most pregnant women 
optimum time for measuring the nuchal book late and may be able to have scan done only 
8 translucency is 10-13 weeks, being 98-100% and toward delivery date . 
9falls to 90% after 14 weeks . In conditions where, 
the ultrasound serves as a secondary diagnostic Screening for chromosomal anomalies is usually 
tool such as ultrasound guided chorionic villus done through combination of maternal serum 
9, 10 sampling, the success of the aspiration in terms biochemistry and maternal age . The earliest 
of ease of tissue yield and abortion rate seems gestation at which the screening can be 
th better when the procedure is performed at performed is 15  week. Screen positive women 
11
about 11-14weeks .are then subjected to invasive procedures, for 
the final diagnosis. This whole process may be 
Chromosomal Abnormalitiestaken up to 2-3weeks and by which period the 
Down's syndrome (DS) is the commonest form of decision to abort an affected fetus is associated 
11 chromosomal observed in clinical practice. The with more hazards .
prenatal screening for DS in the second trimester 
using maternal serum biochemical markers has The first trimester screening for congenital 
been established part of obstetric practice in abnormalities by ultrasonography scan affords 
13
may countries over the past decade .an opportunity for early diagnosis or 
Multicentre studies have reported that confirmation, with bonus affects which include 
ultrasound scan can identify and measure the the fact that the natural history of certain 
fluid collection in the subcutaneous tissue conditions can be assessed, interventional fetal 
9, 14, 15
overlying the cervical spine of the fetus . This therapy can be employed where feasible and 
7 fluid collection is represented by a hypo echoic post natal treatments planned for in advance . In 
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zone, referred to as the nuchal translucency (NT). prevalence of chromosomal abnormalities in 
The introduction of the NT measurement, has fetuses with increased NT was 28.7% and the 
6
range was from 11% to 88% . This variation now replaced the second trimester maternal 
presumably reflects the difference in the serum biochemistry (MSB) in many centers in 
maternal age distribution and the definition of developed countries.
the minimum abnormalities NT, which ranged 
3, 6For the NT measurement to be acceptable, the from 2mm to 10mm .
following minimum expectations must be met (i) Subsequent studies in the mid 90s sought to 
the CRL should be between 45mm and 84mm. clarify the association between maternal age, NT 
which correspond to a gestation between 11 and measurement and risk of chromosomal 
14 weeks calculated from the last menstrual abnormalities. The conclusions were that (i) the 
period, (ii) the maximum thickness should be risk of chromosomal abnormalities increase with 
obtained in the mid sagittal section of the both maternal age and fetal NT thickness and (ii) 
6,7,15,16.
in pregnancies with low fetal NT, the maternal fetuses, using the on-to-on rule  Several 
6, 17, 21reports on the NT measurement in the early age related risk is reduced . Other 
1990s demonstrated an association between prospective Multicentre studies also established  
increased NT and a wide range of chromosomal that (i) in normal pregnancies, fetal NT thickness 
 17,18,19,20
increases with gestation and (ii) that in trisomies abnormalities (Table i) . The mean 
           Abnormal Karyotype (n)
Study/Year      NT thickness (mm) Total                Trisomy 21    Trisomy 18    Trimsomy 13   45X    Others   
Johnson etal/1993                > 2.0  68 41 (60.3%) 16 9 2 9 5
Hewitt/1993          > 2.0 29 12 (41.4%) 5 3 1 2 1
Shulman et al/1992         > 2.5  32 15 (46.9%)  4  4 3 4  -
Nicolaides et al/1992     > 3.0 88 33 (37.5%) 21 8 2 -  2
Ville et al/1992             > 3.0 29 8 (27.6%) 4 3 1 -         -
Wilson et al/1992            > 3.0 14 3 (21.4%)  -    - - 1 2
Trauffer etal/1994             > 3.0 43 21 (48.8%)  9 4 1 4       3
Brambati et al/1995          > 3.0 70 8 (11.45%) ?  ? ? ?         ?
Comas et al/1995            > 3.0 51 9(17.6%)  4 4 - -          1
Pandya et al/1995             > 3.0 1,015 194 (17.6%)101 51 13 14       15
Szabo et al/1995            > 3.0 96 4 (44.8%) 28 10 - 2           3
Shute-Valentin and Schindler/1992   > 4.0 8 7 (87.5%)  7 -        - - -
Van Zalen-sprock et al/1992  > 4.0 18 6 (33.3%)  3 1  - 1 1
Nadel etal/1993      > 4.0 63 43 (68.3%) 15 15 1 10 2
Savoidelli et al/1993               > 4.0 24 19 (79.2%) 15 2 1 1 -
Cullen et al /1990                    > 6.0 29 15 (51.7%)  6 2 -  4 3
Suchet et al/1992      > 10.0 13 8 (61.5%)  -  - - 7 1
Total 1,690, 485(28.7%)  238     116 25 59         39   
Adapted from “Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities” Kypros H. 
Nicolaides
Table 1: Early Reports on the Association Between Increased NT Thickness 
and Chromosomal Abnormalities
54
21 and other major chromosomal abnormalities, optimum decision on the management of the 
6, 16
fetal NT is increased . Although these studies fetus. The practice may however be associated 
were conducted on high-risk population with an with a  h igher  inc idence of  reported 
already increased risk, the applicability of the abnormalities. A study quoted an incidence of 2-
conclusion in an unselected or low risk 6%. This study also agrees with order studies on 
population was confirmed in another series of the superiority of a transvaginal ultrasound over 
22 26, 27studies . transabdominal ultrasound . The detection 
rates of congenital abnormalities is however 
Generally, there is the consensus that risk for improved when both the transabdominal and 
28
t r i s o m i e s  a n d  o t h e r  c h r o m o s o m a l  transvaginal ultrasound scan are combined .
abnormalities, can be derived by the Another important factor for a better outcome of 
multiplication of the a priori maternal age. (Prior the first trimester scans is optimum gestational 
risk) and the gestation related likelihood ratio age at which most of the fetal structures can be 
9, 16(NT deviation from median for the CRL) . The visualized. Studies have demonstrated that the 
+6
screening positive group is based on a risk cut off optimum time is between the 11 and 13  weeks 
6 3, 9of 1 in 300 pregnancies . Any risk above this cut of pregnancy . 66%-86% of congenital 
off is screen positive and above is screen anatomical defects were not recognized by 
negative. ultrasound conducted mainly by practitioners. 
Another important observation from the This is a justification for appropriate training of 
numerous studies was the issues of operator sonographers as recommended by some authors 
variability. This observation justifies the need for based on series of studies at Kings College 
appropriate training of sonographers, adherence hospital, London. Another study from same 
to standard technique and regular auditing of center demonstrates that the detection rate of 
sonographers and images, if NT scan is to be congenital abnormalities can be improved to 
offered routinely as the main screening test for 100% following education and appropriate 
3, 6.chromosomal abnormalities training of sonographers.
There are differences in the incidence of 
congenital abnormalities in the various studies. Structural Abnormalities
In a review from Olabisi Olabisi University For more than two decades, ultrasound has 
Teaching Hospital (OOUTH) and Lagos University proven to be the best technique available for 
10 Teaching Hospital (LUTH) both in Nigeria, the prenatal detection of fetal anatomical defects . 
commonest abnormalities are those of the The incidence of reported structural or 
gastro intestinal system followed by the central anatomical abnormality detected in a high-risk 
29.3023 nervous system . In another study from center by antenatal sonography is 1% . In the 
America, central nervous system abnormalities non-selected population, there may be a 
 31constitute 50% of all cases recorded .decrease in this figure.
Generally, abnormalities involving most systems Many centers in the world conduct prenatal 
can be suspected and defined accurately at the ultrasound screening for structural anomalies 
th early scan. There is however reports that suggest after the 16  week of the gestation, when it is 
that difficulty may be encountered in the believed that the fetus is large and an anomaly 
7,24,25,26 prenatal detection of abnormalities in some image is readily obtained . There are 
other system. The system that is commonly however, conflicting reports on the impact of 
examined with much caution is the heart and such policy, even though it continues to remain 
great vessels. The ultrasound scans of the four the practice.
chambers have resulted in a better pick up rate of 
congenital heart defects. While it is correct that In the last few years, many centers are beginning 
the four chambers view, value and outflow tracts to introduce the early ultrasound examination. 
+6
can always be demonstrated by the 11-13  They may be linked to the facts that an early 
weeks gestation, the accuracy of second recognition of an abnormality allows for an 
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trimester scan is considerably better as and are worthy of consideration.
anomalies of the great arteries in particular are 
31,32often not seen in the first trimester . Although, 1. Training and Standardization
the study suggested that first trimester cardiac As with all aspects of good clinical practices, 
scanning should be confined to pregnancies at operators who perform first trimester scan 
increased risk and should always be followed by should be training appropriately and their results 
as second trimester scan, other studies however should be subjected to external quality 
6
suggest that routine cardiac scan in the first assurance . It has been established that 
trimester and those with any abnormal features satisfactory results are achievable after 80 
sent to fetal echocardiography unit and while transabdominal scans and 100 transvaginal 
6, 9.scans    Several factors have influence on the follow up second trimester scan is done for those 
 31, 32, 33
with normal findings . quality of results. These include gestational age, 
fetal position, and scan resolution and route of 
Some authors have discussed the reliability of scan (TA or TV).
f i rst  tr imester  screening for  skeletal  
abnormalities as well as the interpretation of 2. Routine versus Indicated Ultrasound Scan 
some transient abnormalities of the renal system There remains considerable debate about the 
such as megacystitis and central  nervous place of routine ultrasound scanning in 
34
disorders such as choroids plexus cyst . It is pregnancy. Studies from developing countries 
imperative for sonographers to appreciate these show that most pregnant women look after the 
8, 37, 38
facts in other to reduce the relatively high false first trimester . This group could therefore 
negative rate in reports. not benefit from the 11-14 weeks scan. Although 
there is a widespread availability of scan in most 
There are considerable evidences of an in developing countries, the positive finding rate 
association between the nuchal translucency is still low and ultrasound examination was 
and structural abnormalities. Studies have recommended only when there a clear obstetrics 
39
reasons is clinically established . It is however demonstrated that increased NT measurement 
observed from the study that congenital may be a marker for a wide range of underlying 
16
pathologies . Structural defects that may be mal format ion  was  not  an  important  
identified in the first trimester include considerat ion  to  many phys ic ians  in  
omphalocele, anencephaly, while some others recommending women for scan. Studies have 
such as cardiac and urinary anomalies can only established that most malformations are 
16, 17 29, 30
be identified in the second trimester . It is detected in the postnatal period . This will be 
therefore a justifiable policy to look out in details a justification for routine early ultrasound 
for any structural abnormality in any fetus with screening in pregnancy. In obstetric units in many 
an increase nuchal translucency measurement. developed countries, ultrasound screening is the 
norm as recommended by the Royal College of 
Obstetrician and Gynecologists and more Genetic Disorders
recently, there is the acceptance of early Genetics disorders could occur either as single 
trimester scan as an invaluable procedure in gene defects such as sickle cell disease or genetic 
40obstetric practice .syndromes such as Di george syndromes. The 
early trimester scan can pick up structural 
Several factors are against the implementation markers for some genetic syndrome such as 
of routine early trimester screening in diaphragmatic hernia, and echogenic kidneys. In 
developing countries. Poor awareness of the the prenatal diagnosis for single gene defects it is 
value among both physicians and women is a used as an adjunct to ultrasound guided 
41.  major factor This coupled with poverty and low procedures such as chorionc villus sampling.
literacy level contributed to the poor utilization 
12of a prenatal diagnostic service in Nigeria . Most Ethical Issues in Early Trimester Screening
papers however agreed tat there is the desire There are few ethnical and practical issues with 
and need for early prenatal diagnosis in most par respect to first trimester USS screening for CM, 
76
42, 43of the world. . of what to do when a diagnosed abnormality is 
discordant. This depend ultimately on the 
3. Ultrasound Screening in Twin pregnancy lethality or otherwise of the condition.
Early Trimester Scan in Twin pregnancy offers 
numerous advantages. First the determination Conclusion 
of zygocity is achievable and this has effect on Prenatal Screening of congenital abnormalities 
the future course of the pregnancy. In has been revolutionized with the increasing 
dichorionic twin, the NT measurement in each sophistication of ultrasound devices and imaging 
2, 44fetus provides effective screening that are useful capabilities . Campbell in 1975 suggested that 
6
in the prenatal diagnosis of chromosmalities . In ultrasound was the tool of the future for the 
4 5monochorionic twin, the scan can predict early prenatal abnormally screening . The 
+6 onset of twin-twin transfusion syndrome (TTTS) introduction of the 11-13 weeks scan, which 
and for which endoscopic coagulation of the began in the early 90s, has gained tremendous 
communication vessels can be applied. acceptance among practitioners world wide, 
Increased NT are an early manifestation of TTTS which suggest that the future is now. The 
6, 9in monochorionic twins . benefits are obvious even though it has its 
limitations. With appropriate training and 
The prevalence of structural defects per fetus in reports from centers where it has been 
dizygotic twins is the same as in singleton, implemented, it will definitely take no time 
whereas the rate in monozygotic twin is 23 times before more units embrace this innovation. 
higher. A major challenge in twin gestation is that 
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